UPDATE: Morgan Stanley Reiterates Overweight Rating, Removes PT on Walgreen Company Ahead of Potential Inversion Event

In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company WAG, but removed the $85.00 price target. In the report, Morgan Stanley noted, “Investor call at end of July/early August, providing the stage for WAG/AB management to unveil Step 2, is next catalyst for shares. Inversion, capital structure, and earnings roadmap are key to watch for. We reiterate our OW and would be buyers ahead of potential inversion event.” Walgreen Company closed on Tuesday at $72.48.